Cargando…
Prevalence of radiotherapy, chemotherapy and access to supportive care in cancer in Brazil, China, France, Russia and the USA
OBJECTIVES: The objective of this study is to assess the prevalence of treatment with radiotherapy and/or chemotherapy in the general adult population of five countries (Brazil, China, France, Russia and the USA) and to evaluate the use of different Supportive Care in Cancer (SCC) services. METHODS:...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787726/ https://www.ncbi.nlm.nih.gov/pubmed/35708175 http://dx.doi.org/10.1111/ecc.13636 |
_version_ | 1784858581424668672 |
---|---|
author | Buiret, Guillaume Delvigne, Véronique le Dantec, Guénaëlle Guyonnet‐Debersac, Pascale Taïeb, Charles |
author_facet | Buiret, Guillaume Delvigne, Véronique le Dantec, Guénaëlle Guyonnet‐Debersac, Pascale Taïeb, Charles |
author_sort | Buiret, Guillaume |
collection | PubMed |
description | OBJECTIVES: The objective of this study is to assess the prevalence of treatment with radiotherapy and/or chemotherapy in the general adult population of five countries (Brazil, China, France, Russia and the USA) and to evaluate the use of different Supportive Care in Cancer (SCC) services. METHODS: A total of 11,100 individuals representing the general population over 18 years of age were recruited from the five countries via a rigorous quota sampling method. RESULTS: There are between 4.1% and 8.78% of respondents reported having undergone medical cancer treatment. Among these subpopulations, the use of at least one SCC was reported by 63% to 86% of respondents. The most commonly used SCC was psychological counselling in France, dietary counselling in Brazil and China, participating in a focus group in the USA and using alternative medicine in Russia. Alternative medicines were chosen by 50% to 61% of patients in every country. CONCLUSION: This study provides information on the prevalence of patients treated by chemotherapy and/or radiotherapy in representative populations from five countries. Among them, SCC was widely used. However, these uses varied both in proportion and choice, given the cultural differences in patients' and families' health beliefs and values, differences among organisations, in available resources and in ethics and policies among countries. |
format | Online Article Text |
id | pubmed-9787726 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97877262022-12-28 Prevalence of radiotherapy, chemotherapy and access to supportive care in cancer in Brazil, China, France, Russia and the USA Buiret, Guillaume Delvigne, Véronique le Dantec, Guénaëlle Guyonnet‐Debersac, Pascale Taïeb, Charles Eur J Cancer Care (Engl) Original Articles OBJECTIVES: The objective of this study is to assess the prevalence of treatment with radiotherapy and/or chemotherapy in the general adult population of five countries (Brazil, China, France, Russia and the USA) and to evaluate the use of different Supportive Care in Cancer (SCC) services. METHODS: A total of 11,100 individuals representing the general population over 18 years of age were recruited from the five countries via a rigorous quota sampling method. RESULTS: There are between 4.1% and 8.78% of respondents reported having undergone medical cancer treatment. Among these subpopulations, the use of at least one SCC was reported by 63% to 86% of respondents. The most commonly used SCC was psychological counselling in France, dietary counselling in Brazil and China, participating in a focus group in the USA and using alternative medicine in Russia. Alternative medicines were chosen by 50% to 61% of patients in every country. CONCLUSION: This study provides information on the prevalence of patients treated by chemotherapy and/or radiotherapy in representative populations from five countries. Among them, SCC was widely used. However, these uses varied both in proportion and choice, given the cultural differences in patients' and families' health beliefs and values, differences among organisations, in available resources and in ethics and policies among countries. John Wiley and Sons Inc. 2022-06-16 2022-11 /pmc/articles/PMC9787726/ /pubmed/35708175 http://dx.doi.org/10.1111/ecc.13636 Text en © 2022 The Authors. European Journal of Cancer Care published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Articles Buiret, Guillaume Delvigne, Véronique le Dantec, Guénaëlle Guyonnet‐Debersac, Pascale Taïeb, Charles Prevalence of radiotherapy, chemotherapy and access to supportive care in cancer in Brazil, China, France, Russia and the USA |
title | Prevalence of radiotherapy, chemotherapy and access to supportive care in cancer in Brazil, China, France, Russia and the USA |
title_full | Prevalence of radiotherapy, chemotherapy and access to supportive care in cancer in Brazil, China, France, Russia and the USA |
title_fullStr | Prevalence of radiotherapy, chemotherapy and access to supportive care in cancer in Brazil, China, France, Russia and the USA |
title_full_unstemmed | Prevalence of radiotherapy, chemotherapy and access to supportive care in cancer in Brazil, China, France, Russia and the USA |
title_short | Prevalence of radiotherapy, chemotherapy and access to supportive care in cancer in Brazil, China, France, Russia and the USA |
title_sort | prevalence of radiotherapy, chemotherapy and access to supportive care in cancer in brazil, china, france, russia and the usa |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787726/ https://www.ncbi.nlm.nih.gov/pubmed/35708175 http://dx.doi.org/10.1111/ecc.13636 |
work_keys_str_mv | AT buiretguillaume prevalenceofradiotherapychemotherapyandaccesstosupportivecareincancerinbrazilchinafrancerussiaandtheusa AT delvigneveronique prevalenceofradiotherapychemotherapyandaccesstosupportivecareincancerinbrazilchinafrancerussiaandtheusa AT ledantecguenaelle prevalenceofradiotherapychemotherapyandaccesstosupportivecareincancerinbrazilchinafrancerussiaandtheusa AT guyonnetdebersacpascale prevalenceofradiotherapychemotherapyandaccesstosupportivecareincancerinbrazilchinafrancerussiaandtheusa AT taiebcharles prevalenceofradiotherapychemotherapyandaccesstosupportivecareincancerinbrazilchinafrancerussiaandtheusa |